Delisting risk
RGNT · AMEX · Medical - Instruments & Supplies

Regentis Biomaterials (RGNT)

Develops a cell-free hydrogel implant for focal knee-cartilage repair.

$2.04
Pre-market+0.02 (+0.99%)
At close$2.02(−1.94%)

Something off on this page? Send us feedback.

History

DateEstimateReportedSurprise
Jun 2026
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Jun 30, 2026